当前位置:首页 - 行情中心 - 瑞普生物(300119) - 财务分析 - 资产负债表

瑞普生物

(300119)

  

流通市值:58.50亿  总市值:80.31亿
流通股本:3.39亿   总股本:4.65亿

资产负债表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
流动资产:
  货币资金531,537,248.99568,317,746.66651,187,038.58486,904,900.47
  交易性金融资产1,021,719,559.041,113,158,780.071,042,700,118.271,306,801,332.2
  应收票据及应收账款1,182,274,565.241,120,721,218.551,009,525,204.11,063,343,120.7
  其中:应收票据16,921,277.5420,014,438.2925,925,814.2127,517,345.75
        应收账款1,165,353,287.71,100,706,780.26983,599,389.891,035,825,774.95
  应收款项融资4,268,548.959,446,693.078,322,771.917,901,174.42
  预付款项92,899,791.1284,837,689.7371,341,123.25114,400,386.91
  其他应收款合计82,742,816.0792,907,989.9872,556,976.85102,581,705.32
  存货495,037,126.39521,705,345.38502,117,273.6505,796,956.07
  其他流动资产21,230,371.5624,129,465.4516,852,862.5414,373,740.68
  流动资产合计3,431,710,027.363,535,224,928.893,374,603,369.093,612,103,316.77
非流动资产:
  长期应收款1,267,873.391,344,884.461,491,357.81,621,766.37
  长期股权投资1,465,134,483.551,349,526,868.061,347,828,101.321,148,889,057.32
  其他非流动金融资产47,033,572.8749,066,551.6353,349,733.3753,494,000.85
  投资性房地产31,473,757.9632,471,985.0133,470,212.0934,468,439.14
  固定资产1,562,907,755.11,585,599,739.531,619,177,205.221,561,341,603.22
  在建工程81,273,322.3562,250,720.3631,889,731.3999,571,615.44
  使用权资产6,758,720.315,936,585.288,356,783.6611,355,878.23
  无形资产467,534,274.22470,874,505.29484,053,690.53447,174,489.78
  开发支出199,614,788.15203,577,248.22197,044,437.22199,407,334.35
  商誉445,689,818.37442,989,818.37442,989,818.37442,473,678.38
  长期待摊费用1,400,369.811,417,614.11,397,684.251,460,809.8
  递延所得税资产37,985,122.4537,070,738.5536,947,810.0429,873,629.73
  其他非流动资产31,212,991.4324,972,829.7623,309,774.2747,652,629.57
  非流动资产合计4,379,286,849.964,267,100,088.624,281,306,339.534,078,784,932.18
  资产总计7,810,996,877.327,802,325,017.517,655,909,708.627,690,888,248.95
流动负债:
  短期借款1,109,992,219.53860,927,049.84785,593,744.31736,812,759.18
  应付票据及应付账款527,364,253.14480,319,251.05436,830,223.47488,861,492.51
  其中:应付票据192,848,632149,875,869.86100,810,918.14168,182,006.68
        应付账款334,515,621.14330,443,381.19336,019,305.33320,679,485.83
  预收款项56,791.07129,358.23101,592.775,589,870.4
  合同负债47,529,379.6259,675,653.7572,656,719.4550,846,163.99
  应付职工薪酬37,488,927.8434,607,839.9352,322,917.6836,353,709.82
  应交税费37,757,161.145,148,764.2930,046,426.5843,550,835.73
  其他应付款合计188,462,293.13146,354,125.18180,531,315.13272,684,825.22
  其中:应付利息9,491.37---
        应付股利21,047,00029,750,000--
  一年内到期的非流动负债157,604,450.56302,232,241.31303,719,284.9171,107,589.81
  其他流动负债17,969,864.8928,986,108.0127,804,836.627,022,134.56
  流动负债合计2,124,225,340.881,958,380,391.591,889,607,060.91,732,829,381.22
非流动负债:
  长期借款344,787,196.2360,355,900368,423,036.2624,876,252.89
  租赁负债4,058,787.353,875,078.042,584,702.584,494,564.44
  递延收益97,896,043.1991,015,597.4592,655,861.2858,456,955.93
  递延所得税负债115,984,746.89117,048,747.15118,015,598.77120,188,332.82
  非流动负债合计562,726,773.63572,295,322.64581,679,198.83808,016,106.08
  负债合计2,686,952,114.512,530,675,714.232,471,286,259.732,540,845,487.3
所有者权益(或股东权益):
  实收资本(或股本)464,754,706464,754,706464,754,706464,754,706
  资本公积2,125,296,525.882,144,673,763.432,144,673,763.432,153,002,323.2
  减:库存股191,211,941.65191,211,941.65191,211,941.65191,211,941.65
  其他综合收益45,528.7345,528.7345,528.73-
  盈余公积232,923,953232,923,953232,923,953233,576,150.02
  未分配利润2,074,375,478.482,159,675,210.162,051,896,990.92,013,038,363.14
  归属于母公司股东权益合计4,706,184,250.444,810,861,219.674,703,083,000.414,673,159,600.71
  少数股东权益417,860,512.37460,788,083.61481,540,448.48476,883,160.94
  股东权益合计5,124,044,762.815,271,649,303.285,184,623,448.895,150,042,761.65
  负债和股东权益合计7,810,996,877.327,802,325,017.517,655,909,708.627,690,888,248.95
公告日期2026-08-262026-04-282026-03-312025-10-25
审计意见(境内)标准无保留意见
TOP↑